Skip to main content
Erschienen in: La radiologia medica 12/2016

01.12.2016 | ONCOLOGY IMAGING

Contribution of nonattenuation-corrected images on FDG-PET/CT in the assessment of solitary pulmonary nodules

verfasst von: Ertan Şahin, Ahmet Kara, Umut Elboğa

Erschienen in: La radiologia medica | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

In this study, we aim to determine the diagnostic performance of nonattenuation-corrected (NAC) and attenuation-corrected (AC) FDG-PET/CT images in the assessment of solitary pulmonary nodule (SPN). We reviewed the images of 41 patients who underwent FDG-PET/CT to diagnose SPNs. The visual analysis of FDG uptake intensity in SPN on AC and NAC PET images was made using a four-point score from 1 to 4 on both AC and NAC PET images. The cutoff value of SUVmax and visual uptake scores for malignancy were defined as ≥2.5 and ≥3, respectively. The significant visual uptake (≥2 visual point score) on AC and NAC PET images was considered to be positive 18F-FDG PET findings for lesion detectability. The sensitivity, specificity and diagnostic accuracy were calculated for AC and NAC PET images. Based on the histopathology and imaging data, 22 of the SPNs (54 %) were malignant and 19 of them (46 %) were benign. The sensitivity and NPV were found to be 100 % in the detection of SPNs for AC and NAC PET images. For all SPNs and SPNs ≤2 cm, NAC PET image had a higher diagnostic performance for the SPN characterization as malignant or benign, when compared with AC PET image. The success rates of AC and NAC PET images were found to be similar for the detection of SPNs. NAC PET image had a higher diagnostic performance for the SPN characterization. It is thought that NAC PET image may provide additional contributions for characterization of SPNs.
Literatur
1.
Zurück zum Zitat Sim YT, Poon FW (2013) Imaging of solitary pulmonary nodule: a clinical review. Quant Imaging Med Surg 3:316–326PubMedPubMedCentral Sim YT, Poon FW (2013) Imaging of solitary pulmonary nodule: a clinical review. Quant Imaging Med Surg 3:316–326PubMedPubMedCentral
2.
Zurück zum Zitat Ost D, Fein AM, Feinsilver SH (2003) The solitary pulmonary nodule. N Engl J Med 348:2535–2542CrossRefPubMed Ost D, Fein AM, Feinsilver SH (2003) The solitary pulmonary nodule. N Engl J Med 348:2535–2542CrossRefPubMed
3.
Zurück zum Zitat Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J (2008) Fleischner society: glossary of terms for thoracic imaging. Radiology 246:697–722CrossRefPubMed Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J (2008) Fleischner society: glossary of terms for thoracic imaging. Radiology 246:697–722CrossRefPubMed
4.
Zurück zum Zitat Wahidi MM, Govert JA, Goudar RK, Gould MK, McCrory DC, American College of Chest Physicians (2007) Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132:94–107CrossRef Wahidi MM, Govert JA, Goudar RK, Gould MK, McCrory DC, American College of Chest Physicians (2007) Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132:94–107CrossRef
5.
Zurück zum Zitat Midthun DE (2013) Early diagnosis of lung cancer. F1000 Prime Rep 5:12CrossRef Midthun DE (2013) Early diagnosis of lung cancer. F1000 Prime Rep 5:12CrossRef
6.
Zurück zum Zitat Henschke CI, Yankelevitz DF, Naidich DP, McCauley DI, McGuinness G, Libby DM et al (2004) CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology 231:164–168CrossRefPubMed Henschke CI, Yankelevitz DF, Naidich DP, McCauley DI, McGuinness G, Libby DM et al (2004) CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology 231:164–168CrossRefPubMed
7.
Zurück zum Zitat Bar-Shalom R, Valdivia AY, Blaufox D (2000) PET imaging in oncology. Semin Nucl Med 30:150–185CrossRefPubMed Bar-Shalom R, Valdivia AY, Blaufox D (2000) PET imaging in oncology. Semin Nucl Med 30:150–185CrossRefPubMed
8.
Zurück zum Zitat Blokland JA, Trindev P, Stokkel MP, Pauwels EK (2002) Positron emission tomography: a technical introduction for clinicians. Eur J Radiol 44:70–75CrossRefPubMed Blokland JA, Trindev P, Stokkel MP, Pauwels EK (2002) Positron emission tomography: a technical introduction for clinicians. Eur J Radiol 44:70–75CrossRefPubMed
9.
Zurück zum Zitat Turkington TG (2001) Introduction to PET instrumentation. J Nucl Med Technol 29:4–11PubMed Turkington TG (2001) Introduction to PET instrumentation. J Nucl Med Technol 29:4–11PubMed
10.
Zurück zum Zitat Kapoor V, McCook BM, Torok FS (2004) An introduction to PET-CT imaging. Radiographics 24:523–543CrossRefPubMed Kapoor V, McCook BM, Torok FS (2004) An introduction to PET-CT imaging. Radiographics 24:523–543CrossRefPubMed
11.
Zurück zum Zitat Huang YE, Pu YL, Huang YJ, Chen CF, Pu QH, Konda SD et al (2010) The utility of the nonattenuation corrected 18F-FDG PET images in the characterization of solitary pulmonarylesions. Nucl Med Commun 31:945–951CrossRefPubMed Huang YE, Pu YL, Huang YJ, Chen CF, Pu QH, Konda SD et al (2010) The utility of the nonattenuation corrected 18F-FDG PET images in the characterization of solitary pulmonarylesions. Nucl Med Commun 31:945–951CrossRefPubMed
12.
Zurück zum Zitat Reinhardt MJ, Wiethoelter N, Matthies A, Joe AY, Strunk H, Jaeger U et al (2006) PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation-corrected PET images. Eur J Nucl Med Mol Imaging 33:134–139CrossRefPubMed Reinhardt MJ, Wiethoelter N, Matthies A, Joe AY, Strunk H, Jaeger U et al (2006) PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation-corrected PET images. Eur J Nucl Med Mol Imaging 33:134–139CrossRefPubMed
13.
Zurück zum Zitat Degirmenci B, Wilson D, Laymon CM, Becker C, Mason NS, Bencherif B et al (2008) Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography. Nucl Med Commun 29:614–622CrossRefPubMed Degirmenci B, Wilson D, Laymon CM, Becker C, Mason NS, Bencherif B et al (2008) Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography. Nucl Med Commun 29:614–622CrossRefPubMed
14.
Zurück zum Zitat Dalli A, Selimoglu Sen H, Coskunsel M, Komek H, Abakay O, Sergi C et al (2003) Diagnostic value of PET/CT in differentiating benign from malignant solitary pulmonary nodules. J BUON 18:935–941 Dalli A, Selimoglu Sen H, Coskunsel M, Komek H, Abakay O, Sergi C et al (2003) Diagnostic value of PET/CT in differentiating benign from malignant solitary pulmonary nodules. J BUON 18:935–941
15.
Zurück zum Zitat van Gómez López O, García Vicente AM, Honguero Martínez AF, Jiménez Londoño GA, Vega Caicedo CH, León Atance P et al (2015) (18)F-FDG-PET/CT in the assessment of pulmonary solitary nodules: comparison of different analysis methods and risk variables in the prediction of malignancy. Transl Lung Cancer Res 4:228–235PubMedPubMedCentral van Gómez López O, García Vicente AM, Honguero Martínez AF, Jiménez Londoño GA, Vega Caicedo CH, León Atance P et al (2015) (18)F-FDG-PET/CT in the assessment of pulmonary solitary nodules: comparison of different analysis methods and risk variables in the prediction of malignancy. Transl Lung Cancer Res 4:228–235PubMedPubMedCentral
16.
Zurück zum Zitat Bengel FM, Ziegler SI, Avril N, Weber W, Laubenbacher C, Schwaiger M (1997) Whole-body positron emission tomography in clinical oncology: comparison between attenuation-corrected and uncorrected images. Eur J Nucl Med 24:1091–1098PubMed Bengel FM, Ziegler SI, Avril N, Weber W, Laubenbacher C, Schwaiger M (1997) Whole-body positron emission tomography in clinical oncology: comparison between attenuation-corrected and uncorrected images. Eur J Nucl Med 24:1091–1098PubMed
17.
Zurück zum Zitat Kotzerke J, Guhlmann A, Moog F, Frickhofen N, Reske SN (1999) Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma. Eur J Nucl Med 26:31–38CrossRefPubMed Kotzerke J, Guhlmann A, Moog F, Frickhofen N, Reske SN (1999) Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma. Eur J Nucl Med 26:31–38CrossRefPubMed
18.
Zurück zum Zitat Lonneux M, Borbath I, Bol A, Coppens A, Sibomana M, Bausart R et al (1999) Attenuation correction in whole-body FDG oncological studies: the role of statistical reconstruction. Eur J Nucl Med 26:591–598CrossRefPubMed Lonneux M, Borbath I, Bol A, Coppens A, Sibomana M, Bausart R et al (1999) Attenuation correction in whole-body FDG oncological studies: the role of statistical reconstruction. Eur J Nucl Med 26:591–598CrossRefPubMed
19.
Zurück zum Zitat Joshi U, Raijmakers PG, Riphagen II, Teule GJ, van Lingen A, Hoekstra OS (2007) Attenuation-corrected vs. nonattenuation-corrected 2-deoxy-2-[F-18]fluoro-d-glucose-positron emission tomography in oncology: a systematic review. Mol Imaging Biol 9:99–105CrossRefPubMedPubMedCentral Joshi U, Raijmakers PG, Riphagen II, Teule GJ, van Lingen A, Hoekstra OS (2007) Attenuation-corrected vs. nonattenuation-corrected 2-deoxy-2-[F-18]fluoro-d-glucose-positron emission tomography in oncology: a systematic review. Mol Imaging Biol 9:99–105CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Kim SK, Allen-Auerbach M, Goldin J, Fueger BJ, Dahlbom M, Brown M et al (2007) Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med 48:214–220PubMed Kim SK, Allen-Auerbach M, Goldin J, Fueger BJ, Dahlbom M, Brown M et al (2007) Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med 48:214–220PubMed
21.
Zurück zum Zitat Raylman RR, Kison PV, Wahl RL (1999) Capabilities of two- and three-dimensional FDG-PET for detecting small lesions and lymph nodes in the upper torso: a dynamic phantom study. Eur J Nucl Med 26:39–45CrossRefPubMed Raylman RR, Kison PV, Wahl RL (1999) Capabilities of two- and three-dimensional FDG-PET for detecting small lesions and lymph nodes in the upper torso: a dynamic phantom study. Eur J Nucl Med 26:39–45CrossRefPubMed
22.
Zurück zum Zitat Miller TR, Wallis JW, Grothe RA Jr (1990) Design and use of PET tomographs: the effect of slice spacing. J Nucl Med 31:1732–1739PubMed Miller TR, Wallis JW, Grothe RA Jr (1990) Design and use of PET tomographs: the effect of slice spacing. J Nucl Med 31:1732–1739PubMed
23.
Zurück zum Zitat Houseni M, Chamroonrat W, Basu S, Bural G, Mavi A, Kumar R et al (2009) Usefulness of non attenuation corrected 18F-FDG-PET images for optimal assessment of disease activity in patients with lymphoma. Hell J Nucl Med 12:5–9PubMed Houseni M, Chamroonrat W, Basu S, Bural G, Mavi A, Kumar R et al (2009) Usefulness of non attenuation corrected 18F-FDG-PET images for optimal assessment of disease activity in patients with lymphoma. Hell J Nucl Med 12:5–9PubMed
24.
Zurück zum Zitat Yilmaz F, Tastekin G (2015) Sensitivity of (18)F-FDG PET in evaluation of solitary pulmonary nodules. Int J Clin Exp Med 8:45–51PubMedPubMedCentral Yilmaz F, Tastekin G (2015) Sensitivity of (18)F-FDG PET in evaluation of solitary pulmonary nodules. Int J Clin Exp Med 8:45–51PubMedPubMedCentral
Metadaten
Titel
Contribution of nonattenuation-corrected images on FDG-PET/CT in the assessment of solitary pulmonary nodules
verfasst von
Ertan Şahin
Ahmet Kara
Umut Elboğa
Publikationsdatum
01.12.2016
Verlag
Springer Milan
Erschienen in
La radiologia medica / Ausgabe 12/2016
Print ISSN: 0033-8362
Elektronische ISSN: 1826-6983
DOI
https://doi.org/10.1007/s11547-016-0681-y

Weitere Artikel der Ausgabe 12/2016

La radiologia medica 12/2016 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.